KE
Publicaties op Oncologisch.com
Pirtobrutinib Versus Ibrutinib in Behandeling-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lympho...
BRUIN CLL-313: Gerandomiseerde Fase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patiën...
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.